Artal Group S.A. - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$139,000
-39.3%
276,0000.0%0.01%
-50.0%
Q2 2022$229,000
-43.6%
276,0000.0%0.01%
-29.4%
Q1 2022$406,000
-46.7%
276,0000.0%0.02%
-19.0%
Q4 2021$762,000
-51.1%
276,0000.0%0.02%
-40.0%
Q3 2021$1,559,000
-47.3%
276,0000.0%0.04%
-41.7%
Q2 2021$2,961,000
-52.0%
276,0000.0%0.06%
-45.0%
Q1 2021$6,169,000
-53.5%
276,0000.0%0.11%
-61.8%
Q4 2020$13,256,000276,0000.28%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders